On Wednesday, VersaPay reported its Q2, 2019 results. The company lost $3.45-million on revenue of $2.18-million, a topline that was up 88 per cent over the same period last year.
Management recounted the quarterly highlights, including a deal with MasterCard on a Virtual Card Receivables Service, what it regards as a strong quarter for ARC sales, and a high conversion of its backlog or ARC, wherein 85 per cent all sales came from the United States.
“I’m pleased to announce that VersaPay continued its strong growth for a third consecutive quarter, with total revenues increasing 88 per cent year over year to $2.18-million,” CEO Craig O’Neill said. “ARC continues to be our primary growth driver with growth of 156 per cent year over year to $1.66-million. Our recurring business (ARR) is approximately $7.50-million at the end of the quarter with ARC representing approximately 73 per cent of this figure. As a result, our gross margins were positively impacted, growing to 81 per cent this quarter, up from 75 per cent in Q2 2018.”
Rosenberg says this was a “mixed” quarter that he nonetheless thinks will set up a strong 2020 for VersaPay.
“VersaPay reported revenue of $2.2M in Q2CY19, an increase of 88% compared to revenue of $1.2M in Q2CY18 and slightly ahead of consensus $2.1M,” the analyst says. “VersaPay reported an Adj. EBITDA loss of $2.6M in Q2CY19, which was better than last year’s Adj. EBITDA loss of $2.8M but worse than consensus Adj. EBITDA loss of $2.2M. Revenue growth was driven by strong U.S. activity with 15 new ARC clients signed in the quarter. Product mix with ARC helped improve gross margins north of 80% but higher expenses due to timing of marketing activities negatively impacted profitability.”
In a research update to clients today, Rosenberg maintained his “Buy” rating and one-year price target of $2.30 on VersaPay, implying a return of 29 per cent at the time of publication. He categorizes the risk factor on the stock as “Very High”.
Rosenberg thinks VPY will post Adjusted EBITDA of negative $9.6-million on revenue of $9.3-million in fiscal 2019. He expects those numbers will improve to Adjusted EBITDA of negative $4.4-million on a topline of $16.5-million the following year.
The analyst says the stock remains cheap when compared to its peers.
“VersaPay is currently trading at 4.7x EV/Revenue of our CY20 estimates vs. the peer group average at 5.0x EV/Revenue multiple of CY20 estimates,” he notes.
And while some investors may be spotting a trend of softness from VPY, Rosenberg says better things are bubbling beneath the surface.
“Following a few soft growth quarters, VersaPay is now showing signs of improvement with a strong backlog, ARR growth and new customer wins,” he writes. “We maintain our target price of $2.30 and believe VersaPay offers an attractive return to investors at these levels.”
Canada’s labour market has softened sharply since the start of the year, with the unemployment rate reaching 7% in May,… [Read More]
Count RBC Capital Markets analyst Ken Herbert among the believers in MDA (MDA Stock Quote, Chart, News, Analysts, Financials TSX:MDA).… [Read More]
Roth Capital Markets analyst Suji Desilva said in a July 3 report that Netlist (Netlist Stock Quote, Chart, News, Analysts,… [Read More]
Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares… [Read More]
Haywood Capital Markets analyst Gianluca Tucci reiterated a “Buy” rating on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts,… [Read More]
Roth Capital Markets analyst Suji Desilva maintained a “Buy” rating and US$18.00 target on D-Wave Quantum (D-Wave Quantum Stock Quote,… [Read More]